Changes in 2013 for OncoImmunology

Beginning in 2013 with Volume 2, OncoImmunology will become an online-only journal. For more information about the change to an electronic publication, please contact the Managing Editor.

In this issue

OncoImmunology
Volume 2, Issue 5
May 2013
View current issue
About the cover
Prostate cancer stem cells cultured on a matrigel-coated round glass slide for 48 h and fixed and stained for STEAP (red) and DAPI (blue), photographed...
Continue reading

Submit to OncoImmunology

OncoImmunology utilizes an online submission and tracking system designed to provide efficient service to authors. Through the online system, author files are automatically converted to PDFs, submissions are acknowledged by email, and authors can track their manuscript through the stages of the peer review process.

Note to Potential Authors - Free Open Access until January 2014

Page and color charges are waived for the first year of publication and the final version of accepted manuscripts will be posted on the web site promptly. Any content posted on the web site from now until January 2014 will always be free. Authors will receive a free print version of the issue containing their paper. For additional information on how to submit your manuscript please click here.

MIATA Compliance

The immune monitoring community has recently established the consensus framework MIATA(“Minimal Information About T Cell Assays”) for reporting of T-cell assay results, which promote objective and thorough interpretation of data and the comparability of results. OncoImmunology supports and encourages the implementation of the MIATA guidelines.

Upcoming Meetings

Hematopoiesis- Keystone Symposium
Jan. 14-19, 2013
Steamboat Springs, CO

Emerging Topics in Immune System Plasticity: Cellular Networks, Metabolic Control and Regeneration
January 15-20, 2013
Santa Fe, New Mexico

Biomarkers Summit
Janurary 16-17, 2013
London, UK

Noncoding RNAs in Development and Cancer- Keystone Symposium
January 20-25, 2013
Vancouver, British Columbia, Canada

Antibodies as Drugs- Keystone Symposium
January 27 - Feb 1, 2013 
Vancouver, British Columbia, Canada

Cancer Research Center of Lyon Symposium
February 13-15, 2013
Lyon, France

Autophagy, Inflammation and Immunity- Keystone Symposium
February 17 - 22, 2013 
Montreal, QC, Canada

2nd Biotechnology World Congress
February 18-21, 2013
Dubai, UAE

PI 3-Kinase and Interplay with Other Signaling Pathways/ Tumor Metabolism- Keystone Symposium
February 24 - Mar 1, 2013 
Keystone, Colorado, USA

Imaging in Cancer Drug Development
March 13-14
London, UK

2nd Annual Cancer Immunotherapy Conference
April 4-5, 2013
Washington DC

V InterAmerican Oncology Conference
October 10 - October 11, 2013
Buenos Aires, Argentina

Editors-in-Chief

Guido Kroemer
University of Paris Descartes

Laurence Zitvogel
INSERM, Institut Gustave Roussy

Lorenzo Galluzzi
Université Paris Descartes/Paris V; Sorbonne Paris Cité

 

Email the Managing Editor, Daniel Olasky.
Print ISSN: 2162-4011
Online ISSN: 2162-402X
Abstracted/Indexed In:
PubMed Central

OncoImmunology is

the official journal of the European Academy of Tumor Immunology

Find us on Facebook

Advertisements